Mergers and Acquisitions

The U.S. drug maker's shares advanced only modestly as Roche denied having a need to raise cash. 

Wall Street may still be dominated by men, but a pair of female bankers played key roles in the mega Verizon Wireless deal.

The Big Board owner has reportedly tapped two leading investment banks to run a possible IPO of its Euronext unit.

Sony rallied on a report that it has hired investment bankers to review a hedge-fund plan to sell part of its entertainment unit.

Pfizer Inc and Allergan Plc are considering combining, the Wall Street Journal said on Wednesday.

Celgene Corp. has reached a deal to buy fellow biopharmaceutical company Receptos Inc. for about $7.2 billion, enhancing its portfolio of immune-inflammatory disease treatments with the addition of Ozanimod.

The scientific and lab equipment maker will sell part of its business to GE Healthcare for about $1.06 billion.

Amgen said over the weekend it would  buy cancer drug maker Onyx Pharmaceuticals  for about $10.4 billion in one of the biggest-ever biotech deals.

St. Jude Medical agreed to buy Endosense for up to $230 million, providing it with catheter technologies that can be used during heart surgeries.

Onyx Pharmaceuticals has reportedly been approached by a slew of drug giants, including Pfizer and Novartis. 

Shares of Onyx Pharmaceuticals surged 51% after the drug giant turned down a buyout offer from Amgen and said it was actively pursuing bids.

Novartis agreed to sell its blood transfusion testing unit to Spain's Grifols for $1.68 billion.

Community Health Systems said it will scoop up smaller rival Health Management Associates  for $3.9 billion to strengthen its base amid tumult in the health-care industry.

Nestle agreed to sell most of its Jenny Craig diet business to the private equity firm as the world’s largest food group looks to slim down.

Aetna Inc. said Friday that it had agreed to buy Humana Inc. for $34.1 billion in cash and stock, following weeks of frenzied merger talks among the largest health insurers.

Health insurer Aetna's proposed acquisition of smaller rival Humana Inc was approved by the shareholders of both companies.

The Chemours Co. is closing its Delaware titanium dioxide production facility, which employs about 200 workers, the former performance chemicals business spun off from the DuPont Co. said Thursday.

A little-used gas-fired power plant built by the Southern Montana Electricity Generation and Transmission Cooperative and at least partly blamed for the wholesale electricity supplier's 2011 bankruptcy will be taken apart and resold for its parts.

European Union regulators on Tuesday approved Pfizer's $15.23 billion purchase of injectable drug and infusion device maker Hospira.

McGraw Hill Financial, owner of ratings agency Standard & Poor's, is buying SNL Financial for about $2.23 billion.